Neil Churchill, Chief Executive at Asthma UK, said: 'We are extremely disappointed that NICE has decided not to recommend Xolair for children under the age of 12. This action will deny children across England with the most severe, allergic asthma, a pioneering treatment that many doctors tell us they want to prescribe and that could free these children from endless trips to hospital and huge amounts of time off school.

It is good news however, that the guidance indicates that those children who have already trialled Xolair and had their lives transformed, should not have their treatment withdrawn by their PCTs. We are also urging PCTs to consider exceptional funding for the very small number of children who would derive significant benefit from Xolair.'

Source:
Asthma UK

View drug information on Xolair.